With 2 ETFs traded on the U.S. markets, Loncar ETFs have total assets under management of $63.89M. The average expense ratio is 0.79%. Loncar ETFs can be found in the following asset classes:
The largest Loncar ETF is the Loncar Cancer Immunotherapy ETF CNCR with $45.65M in assets. In the last trailing year, the best-performing Loncar ETF was CHNA at 42.33%. The most recent ETF launched in the Loncar space was the Loncar China BioPharma ETF CHNA on 08/14/18.
Like punk rock, alpha is very much alive.
The volatile segment struggled to catch a break, then rallied, and now sits in the limelight of a virus outbreak.
Latest ETF to come to market aims to offer unique access to an emerging hot sector only one other ETF focuses on today.
Bloomberg ETF analyst discusses what’s going on with ETFs in 2018.
These funds give investors exposure to niche areas of the market.
The ISE isn’t just an options exchange; it’s now a mostly unseen player in the ETF industry.
This directory provides a comprehensive list of all the new players in the ETF space and their operations.
The hot segment could use more segmentation, Brad Loncar says.
The rise of RQFII ETFs means it's time to prepare for more innovation from China and broad emerging market ETFs.
